Assessment and first steps: Confirm insomnia as difficulty initiating or maintaining sleep, or poor sleep quality, despite adequate opportunity, with impaired daytime functioning; sleep disturbance without daytime impairment is not insomnia disorder. NICE CKS
Assess symptom pattern, duration, frequency, functional impact, sleep schedule and environment, triggers, substance use, medicines, and physical or mental-health comorbidity. NICE CKS
Ask about snoring, witnessed apnoea, restless legs and parasomnias, and consider obstructive sleep apnoea screening where appropriate. NICE CKS
Use a 1–2 week sleep diary to identify sleep patterns and perpetuating lifestyle factors. NICE CKS
Non-pharmacological management: Offer sleep-hygiene advice to everyone, addressing behavioural, environmental and timing factors that can impair or improve sleep. NICE CKS
Offer cognitive behavioural therapy for insomnia (CBTi) as first-line treatment for both short-term and chronic insomnia in adults of all ages; its benefits persist after treatment ends. NICE CKS
Sleepio, a digitally delivered CBTi programme, can be offered. NICE CKS
Pharmacological management: Avoid hypnotics where possible because of their potential for significant adverse effects, and avoid pharmacological therapy for long-term management. NICE CKS
For short-term insomnia that is likely to resolve soon but causes severe daytime impairment and significant distress, consider a 3–7 day course of a non-benzodiazepine hypnotic (z-drug), avoiding these where possible in older people. NICE CKS
For short-term insomnia that is unlikely to resolve soon, offer CBTi first line; short-term adjunctive treatment with a z-drug, or prolonged-release melatonin for people aged over 55 years, may be appropriate. NICE CKS
If prescribing zopiclone, use the lowest effective dose and do not use it continuously long term. SmPC Zopiclone
Review and referral: Refer to a sleep clinic or neurology if another sleep disorder is suspected, the diagnosis is uncertain, or long-term insomnia has not responded to primary-care management. NICE CKS
Key References
- NICE CKS: Insomnia
- NICE CG78: Borderline personality disorder: recognition and management
- SmPC: Zopiclone 7.5mg film-coated tablets
- SmPC: Zopiclone 3.75mg film-coated tablets
- NICE CKS: Restless legs syndrome
- SmPC: Nitrazepam Mixture 2.5mg/5ml Oral Suspension BP
- NICE CG170: Autism spectrum disorder in under 19s: support and management
- NICE NG202: Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over 16s